2018 Digital Health Forum

  • 20 November, 2018
  • 9:00am - 3:30pm

The NIHA Digital Health Forum will bring together key thought leaders from the medical-technology industry and various government agencies to discuss the current digital healthcare landscape in Asia-Pacific. Providing a neutral platform for healthcare professionals, regulators, industry and innovators, this forum will discuss issues surrounding healthcare innovation within the region. This event will be of interest to professionals from medical-device enterprises, healthcare service sectors, and members from both regulatory and government institutions.

APEC RHSC CoE Pilot Workshop - Biotherapeutics and Biosimilars

  • 29 October, 2018 to 30 October, 2018
  • 9:00am - 6:00pm

Biotherapeutics, or medicinal products manufactured using living cells or tissues, are the trending developments from leading pharmaceuticals in the treatment of conditions related to oncology and immunology among others. The exponential progression in science and medical practices necessitates all involved or interested in this field to keep current with the developments. In particular, the increasing production of biosimilars, or generics of biotherapeutics, demands the attention of regulatory professionals. In the context of the complex scientific knowledge and the evolving understanding of good practices in regulating these products, this APEC Regulatory Harmonisation Steering Committee pilot Workshop, in conjunction with the APEC Harmonisation Centre, aims to provide the necessary foundations in understanding the regulatory controls for these innovations, including aspects of quality, non-clinical and clinical considerations.

Biotherapeutics and Biosimilars Course

  • 29 October, 2018 to 2 November, 2018
  • 9:00am - 6:00pm


The advent of biotherapeutics and biosimilars highlighted the need for regulatory affairs to accommodate the rapidly evolving medical sciences, necessitating timely revisions in policies, processes and the technical knowledge in managing these new innovations and facilitating access to meet medical needs. This four-credit module provides the background to the rise of these biologicals in healthcare, and the defining differences from traditional pharmaceuticals and generics. There is a focus on post-market activities which serve as the main guards for ensuring the safe use of these products. Click here to register for the GMS5104:Biotherapeutics and Biosimilars Course as a participant.

Delivering Value with Innovative Healthcare Financing and Systems

  • 12 October, 2018
  • 9:00am - 12:00pm

As Singapore embarks on system-wide changes in healthcare delivery, public and private actors see a window of opportunity to increase the understanding of value-based care delivery and financing models that link reimbursement to population health outcomes. At this symposium, speakers will provide global perspectives for advancing high-value health care, touching on cost sustainability, financing models to support innovation, and lessons that Singapore can incorporate into the local health system. Key stakeholders from the health ministry, healthcare clusters, and academia will share current efforts, opportunities and challenges in implementation of innovative healthcare financing models in Singapore.

CoRE Symposium 2018: New Visions for Advancing Regulatory Science and Public Health

  • 3 October, 2018
  • 2:00pm - 5:00pm

Adapting patient care to an environment of evolving medical knowledge and innovative product development demands a sharp ability to forecast the upcoming needs of the future. Regulatory systems are expected to support innovation and facilitate patients’ access to new effective treatments.

The increasing involvement of patients in shaping health policies and decision-making indicates the progressive movement towards patient-centric care. In light of these trends, various stakeholders are responding to the changing environment and adapting to accommodate new demands.

Hear from the speakers, as they share from their experiences and present global perspectives in envisioning optimal approaches for advancing public health. 

Graduate Certificate in Pharmaceutical Regulation Registration Form

  • Graduate Certificate Registration

Thank you for your interest in our Graduate Certificate Programme. Please click below to sign up for GMS5104:Biotherapeutics and Biosimilars Course.

WHO-UMC-HSA Inter-Regional Pharmacovigilance Training workshop

  • 15 August, 2018 to 17 August, 2018
  • 9:00am - 6:00pm


Expert pharmacovigilance trainers from the World Health Organisation (WHO), the Uppsala Monitoring Centre (UMC), and the Health Sciences Authority (HSA) of Singapore, will share with participants their expertise and experience over a 3-day workshop, jointly organised with the WHO, UMC, HSA, and CoRE, as part of a continuation of efforts to enhance pharmacovigilance capabilities in the ASEAN region. Given this year’s underlying theme of “Partnerships to Protect Public Health”, we welcome participation from non-regulators, such as people from the industry and non-government organisations (NGOs).

APEC RHSC CoE Pilot Workshop: Advanced Therapies 2018

  • 23 July, 2018 to 25 July, 2018
  • 8:30am - 6:00pm


Advanced Therapies is a rapidly advancing field that offers exciting new therapeutic possibilities. To promote a better understanding of the frameworks and processes regulating cell, tissue, and gene therapies, this 2.5-day workshop provides a platform for global and regional experts to share their expertise and experience, including major and regional regulatory authorities, as well as leading companies in this domain. This second pilot workshop has been co-developed with guidance from APEC Life Sciences Innovation Forum Regulatory Harmonization Steering Committee (RHSC) and a programme committee consisting of the Health Sciences Authority (HSA) Singapore, and key opinion leaders from industry and scientific organisations.

Seminar Series: What’s Happening In China? An Update on the Latest Regulatory Developments

  • 17 July, 2018
  • 3:30pm - 5:00pm

Following up on CoRE’s previous Seminar Series on regulatory developments in China, China's regulatory agency has since met all of its objectives to initiate reforms to its regulatory frameworks in 2017. This resulted in a reduction of lag time, increase in regulatory capacity and the implementation of a science-based regulatory review approach. To further improve China’s regulatory environment, the Deepening Reform was implemented in October 2017 which has resulted in the publication of various new guidelines, regulations and requirements. In light of these rapid and successive changes, this seminar examines the key reforms and their impact on the global regulatory environment in the near future.

Seminar Series: E-labelling - Connecting Patients through Technology

  • 21 May, 2018
  • 3:30pm - 5:00pm

Accessibility to accurate and reliable information is essential to healthcare professionals and patients for ensuring the safe and correct use of health products. A trend of providing electronic product information, or e-labelling, over the use of traditional printed labels is accelerating. This shift in improving accessibility to information opens up exciting possibilities for health literacy, but also raises concerns. The advent of the internet and social media has resulted in an explosion of alternative information sources, increasing the risk of accessing incorrect information, and potentially compromising the appropriate use of health products. CoRE welcomes you to join us for this seminar with Dr Shimon Yoshida on the potential for e-labelling in Asia and sharing initiatives from other parts of the world. Closing the seminar will be a panel discussion with representatives from the healthcare sector, regulatory authority and industry to further discuss the contemporary topic of e-labelling.